Skip to main content
Top
Literature
1.
go back to reference Tschoepe D, Menart B, Ferber P et al. (2003) Genetic variation of the platelet surface integrin GPIIb-IIIa (PIA1/PIA2-SNP) shows a high association with Type 2 diabetes mellitus. Diabetologia 46:984–989CrossRefPubMed Tschoepe D, Menart B, Ferber P et al. (2003) Genetic variation of the platelet surface integrin GPIIb-IIIa (PIA1/PIA2-SNP) shows a high association with Type 2 diabetes mellitus. Diabetologia 46:984–989CrossRefPubMed
2.
go back to reference Tschoepe D, Menart B, Haastert B, Holle R, Roesen P, Loewel H (2002) The thrombogenic PIA2 allele variant of the platelet fibrinogen receptor GPIIbIIIa is linked with diabetic HbA1c values—results from a representative population sample (the KORA 2000 survey). Diabetologia 45 [Suppl 2]:A408 Tschoepe D, Menart B, Haastert B, Holle R, Roesen P, Loewel H (2002) The thrombogenic PIA2 allele variant of the platelet fibrinogen receptor GPIIbIIIa is linked with diabetic HbA1c values—results from a representative population sample (the KORA 2000 survey). Diabetologia 45 [Suppl 2]:A408
3.
go back to reference Bojesen SE, Juul K, Schnohr P, Tybjaerg-Hansen A, Nordestgaard BG (2003) Platelet glycoprotein IIb/IIIa PIA2/PIA2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study. J Am Coll Cardiol 42:661–667CrossRefPubMed Bojesen SE, Juul K, Schnohr P, Tybjaerg-Hansen A, Nordestgaard BG (2003) Platelet glycoprotein IIb/IIIa PIA2/PIA2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study. J Am Coll Cardiol 42:661–667CrossRefPubMed
Metadata
Title
Author’s Reply
Author
D. Tschoepe
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1398-3

Other articles of this Issue 5/2004

Diabetologia 5/2004 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.